Table 3 Patient Characteristics.

From: In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI

No.

Sex

Age

AJCC T stage

RG/NRG

1

M

62

T3N2M0

NRG

2

M

23

T4N2M0

NRG

3

M

45

T3N2M0

NRG

4

F

53

T2N2M0

NRG

5

M

41

T4N3M0

NRG

6

M

56

T3N2M0

RG

7

M

48

T2N1M0

RG

8

F

57

T2N3M0

RG

9

M

66

T2N2M0

RG

10

M

57

T3N2M0

RG

11

M

41

T2N2M0

RG

12

M

65

T2N0M0

RG

13

M

63

T2N3M0

RG

14

M

65

T2N1M0

RG

15

F

67

T2N1M0

RG

16

F

62

T2N1M0

RG

17

M

57

T2N1M0

RG

18

M

76

T2N1M0

RG

19

F

45

T3N1M0

RG

20

M

20

T3N3M0

RG

21

M

30

T3N3M

RG

22

M

46

T3N1M0

RG

23

M

41

T3N2M0

RG

24

M

64

T3N3M0

RG

25

F

65

T4N2M0

RG

26

F

50

T2N1M0

RG

27

F

48

T3N3M0

RG

28

M

77

T2N2M0

RG

29

F

35

T3N2M0

RG

30

M

30

T4N3M0

RG

31

M

35

T4N2M0

RG

32

F

45

T3N1M0

RG

33

M

20

T3N3M0

RG

34

M

30

T3N3M0

RG

35

M

46

T3N1M0

RG

36

M

41

T3N2M0

RG

37

M

64

T3N3M0

RG

38

F

65

T4N2M0

RG

39

M

53

T2N2M0

RG

40

F

57

T3N3M0

RG

41

M

62

T2N3M0

RG

  1. M: male, F: female; AJCC: American Joint Committee on Cancer; RG: Response group; NRG: No-response group.